Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)

Hong Kong · Delayed Price · Currency is HKD

4.500

0.00 (0.00%)

May 7, 2026, 3:43 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Pharmaceuticals	33.36M	71.87M	66.64M	32.82M	71.06M
Pharmaceuticals Growth	-53.57%	7.85%	103.03%	-53.82%	-
Total	33.36M	71.87M	66.64M	32.82M	71.06M
Total Growth	-53.57%	7.85%	103.03%	-53.82%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
China	33.36M	71.87M	66.64M	32.82M	71.06M
China Growth	-53.57%	7.85%	103.03%	-53.82%	-
Total	33.36M	71.87M	66.64M	32.82M	71.06M
Total Growth	-53.57%	7.85%	103.03%	-53.82%	-

Source: S&P Global Market Intelligence.